Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38301 - 38325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	RAB31	11031	upregulated	entinostat results in increased expression of RAB31 mRNA	18p11.22	A21037 A21035
Entinostat	Investigational	RAB33A	9363	downregulated	entinostat results in decreased expression of RAB33A mRNA	Xq26.1	A21037
Entinostat	Investigational	RAB37	326624	upregulated	entinostat results in increased expression of RAB37 mRNA	17q25.1	A21037 A21035
Entinostat	Investigational	RAB3A	5864	upregulated	entinostat results in increased expression of RAB3A mRNA	19p13.11	A21037
Entinostat	Investigational	RAB42	115273	upregulated	entinostat results in increased expression of RAB42 mRNA	1p35.3	A21035
Entinostat	Investigational	RABGAP1L	9910	upregulated	entinostat results in increased expression of RABGAP1L mRNA	1q25.1	A21037
Entinostat	Investigational	RAC2	5880	upregulated	entinostat results in increased expression of RAC2 mRNA	22q13.1	A21037 A21035
Entinostat	Investigational	RALGAPA2	57186	downregulated	entinostat results in decreased expression of RALGAPA2 mRNA	20p11.23	A21035
Entinostat	Investigational	RAP1GAP2	23108	upregulated	entinostat results in increased expression of RAP1GAP2 mRNA	17p13.3	A21037
Entinostat	Investigational	RAP1GDS1	5910	downregulated	entinostat results in decreased expression of RAP1GDS1 mRNA	4q23	A21037
Entinostat	Investigational	RAPGEF4-AS1	91149	downregulated	entinostat results in decreased expression of RAPGEF4-AS1 mRNA	2q31.1	A21035
Entinostat	Investigational	RARB	5915	upregulated	entinostat results in increased expression of RARB mRNA	3p24.2	A21037
Entinostat	Investigational	RARRES2	5919	upregulated	entinostat results in increased expression of RARRES2 mRNA	7q36.1	A21037
Entinostat	Investigational	RASA2	5922	downregulated	entinostat results in decreased expression of RASA2 mRNA	3q23	A21037
Entinostat	Investigational	RASEF	158158	upregulated	entinostat results in increased expression of RASEF mRNA	9q21.32	A21037 A21035
Entinostat	Investigational	RASGEF1A	221002	upregulated	entinostat results in increased expression of RASGEF1A mRNA	10q11.21	A21037 A21035
Entinostat	Investigational	RASGRP2	10235	upregulated	entinostat results in increased expression of RASGRP2 mRNA	11q13.1	A21037 A21035
Entinostat	Investigational	RASL11B	65997	upregulated	entinostat results in increased expression of RASL11B mRNA	4q12	A21037
Entinostat	Investigational	RASL12	51285	upregulated	entinostat results in increased expression of RASL12 mRNA	15q22.31	A21037 A21035
Entinostat	Investigational	RASSF3	283349	upregulated	entinostat results in increased expression of RASSF3 mRNA	12q14.2	A21037
Entinostat	Investigational	RASSF4	83937	upregulated	entinostat results in increased expression of RASSF4 mRNA	10q11.21	A21035
Entinostat	Investigational	RASSF8-AS1	100506451	downregulated	entinostat results in decreased expression of RASSF8-AS1 mRNA	12p12.1	A21037
Entinostat	Investigational	RAX	30062	downregulated	entinostat results in decreased expression of RAX mRNA	18q21.32	A21037
Entinostat	Investigational	RBBP4	5928	downregulated	entinostat results in decreased expression of RBBP4 mRNA	1p35.1	A21035
Entinostat	Investigational	RBFOX3	146713	upregulated	entinostat results in increased expression of RBFOX3 mRNA	17q25.3	A21037

Displaying entries 38301 - 38325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability